about
Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugsDrug-Metabolizing Enzymes and Metabolic Diseases: Role of Antioxidants.N-nitrosamines induced infertility and hepatotoxicity in male rabbits.Regulation of glycolipid sulfotransferase by tyrosine kinases in human renal cancer cells.Nigella sativa Relieves the Altered Insulin Receptor Signaling in Streptozotocin-Induced Diabetic Rats Fed with a High-Fat Diet.Anti-diabetic activity of different oils through their effect on arylsulfatases.Epidermal growth factor, its receptor and transforming growth factor-β1 in the diagnosis of HCV-induced hepatocellular carcinoma.Zinc and curcumin lower arylsulfatses and some metabolic parameters in streptozotocin-induced diabetes.Succinate cytochrome c reductase in schistosomiasis: in vitro inhibition by some schistosomicidal drugs.In vitro effect of schistosomicidal drugs on hepatic arylsulfatase B from the schistosoma-infected mouse.Inhibition of some hepatic glycosidases by the diseco nucleoside, 4-amino-3-(D-glucopentitol-1-yl)-5-mercapto-1,2,4-triazole and its 3-methyl analog.Effect of calcium treatment on blood parameters, gonadal development and the structure of bone in immature female rats.The clinical relevance of urine-based markers for diagnosis of bladder cancer.Alterations of protein kinase isozymes in transplantable human lung cancer with special reference to the phosphorylation of arylsulfatase BMechanism of pepsin-catalyzed aminotranspeptidation reactionsSecondary substrate binding in aspartic proteinases: contributions of subsites S3 and S'2 to kcatInhibition of some hepatic lysosomal glycosidases by ethanolamines and phenyl 6-deoxy-6-(morpholin-4-yl)-beta-D-glucopyranosideCYP1A1, CYP2E1, and GSTM1 gene polymorphisms and susceptibility to colorectal and gastric cancer among LebaneseThe protective mechanism of Nigella sativa against diethylnitrosamine-induced hepatocellular carcinoma through its antioxidant effect and EGFR/ERK1/2 signalingSynergistic effect of nano-selenium and metformin on type 2 diabetic rat model: Diabetic complications alleviation through insulin sensitivity, oxidative mediators and inflammatory markersInhibition of mammalian aspartate transcarbamylase by quinazolinone derivatives
P50
Q36372009-66200BC9-89BC-485C-8C5A-0002374A12EAQ37443137-463E647A-AEDC-4443-9E6C-61AAB10D17ADQ38749376-BDD1414E-5480-4BF4-8292-7955DA973467Q41240431-96DAA8E7-4CFB-4DAE-B75D-56DC688E3266Q41694546-06A00C17-2489-4F4D-A6D5-B946DF1EA637Q42092821-1CB8C353-8C58-48DF-B97E-2569ABE6D611Q42279286-FD4401F1-C593-40DB-8A47-303864E8B68FQ42316677-B381431B-7E2F-4BC1-A203-445B31352D49Q42948652-BCE9E6D2-22C1-42A8-8E87-4EFD97B4118EQ46396071-8B1DD355-6653-4268-85FF-CD7154D8B2C7Q46529783-D3D8E516-5B04-49EF-A0CF-B3342ABE37CFQ51379876-CB6EEF2F-1A73-4327-B09E-1194D05F4421Q54381208-8D1E0747-38F6-4FCB-ACF1-17B933997509Q69815836-DB6C03AB-1B01-4DA9-9CA3-D3114A2951B2Q72315782-AF46FFA9-5757-4707-BA6F-88332B6AAA26Q72545181-E05AAEFF-43A1-4E10-9EAE-494AA9649AE6Q78184267-97A4E83D-DBDE-4520-9FC7-10F0164485AAQ83562316-50F45968-2E94-430D-8AE6-6E8BCABE15D3Q89162978-3EA3A068-D2B5-48BE-916F-8FB539EB5995Q92816527-432EA64A-FFD4-44EF-8DAC-166D90BF3E6CQ94705213-7632F28A-B0B4-4743-974A-FB420D327449
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Mahmoud Balbaa
@ast
Mahmoud Balbaa
@en
Mahmoud Balbaa
@es
Mahmoud Balbaa
@nl
Mahmoud Balbaa
@sl
type
label
Mahmoud Balbaa
@ast
Mahmoud Balbaa
@en
Mahmoud Balbaa
@es
Mahmoud Balbaa
@nl
Mahmoud Balbaa
@sl
prefLabel
Mahmoud Balbaa
@ast
Mahmoud Balbaa
@en
Mahmoud Balbaa
@es
Mahmoud Balbaa
@nl
Mahmoud Balbaa
@sl
P108
P106
P1153
6602072402
P21
P31
P496
0000-0002-0876-6604
P569
2000-01-01T00:00:00Z